Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COSMOS-Avatar: Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX

NCT06782971 is registered in ClinicalTrials.gov with Clinical Hub for Interventional Research (CHOIR) as lead sponsor.

NCT NCT06782971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06782971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COSMOS-Avatar: Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX
Lead sponsor
Clinical Hub for Interventional Research (CHOIR)
Phase
Observational
Overall status
Recruiting
Start date
June 6, 2025
Completion date
March 31, 2030
Enrollment
25 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

aml - acute myeloid leukemia